[HTML][HTML] Addressing Sexually Transmitted Infections Due to Neisseria gonorrhoeae in the Present and Future

J Colón Pérez, RA Villarino Fernández… - Microorganisms, 2024 - mdpi.com
It was in the 1800s when the first public publications about the infection and treatment of
gonorrhoea were released. However, the first prevention programmes were only published …

Gonococcal Mimitope Vaccine Candidate Forms a Beta-Hairpin Turn and Binds Hydrophobically to a Therapeutic Monoclonal Antibody

PT Beernink, C Di Carluccio, R Marchetti, L Cerofolini… - JACS Au, 2024 - ACS Publications
The spread of multidrug-resistant strains of Neisseria gonorrhoeae, the etiologic agent of
gonorrhea, represents a global health emergency. Therefore, the development of a safe and …

Mucosal adjuvanticity and mucosal booster effect of colibactin-depleted probiotic Escherichia coli membrane vesicles

H Uchiyama, T Kudo, T Yamaguchi… - Human Vaccines & …, 2024 - Taylor & Francis
There is a growing interest in development of novel vaccines against respiratory tract
infections, due to COVID-19 pandemic. Here, we examined mucosal adjuvanticity and the …

[HTML][HTML] Leveraging Immunofocusing and Virus-like Particle Display to Enhance Antibody Responses to the Malaria Blood-Stage Invasion Complex Antigen PfCyRPA

KH Björnsson, MR Bassi, AS Knudsen, KL Aves… - Vaccines, 2024 - mdpi.com
A vaccine protecting against malaria caused by Plasmodium falciparum is urgently needed.
The blood-stage invasion complex PCRCR consists of the five malarial proteins PfPTRAMP …